Latest News
OEHHA received the following comments after OEHHA provided notice on December 17, 2010 of the proposed rulemaking - Title 22, California Code of Regulations, Sections 69401 Through 69406 - Green Chemistry Toxics Information Clearinghouse Identification of Hazard Traits, Endpoints and Other Relevant Data for Inclusion in the Toxics Information Clearinghouse.
Feb 28, 2011, Program: Risk Assessment
S,S,S-tributyl phosphorotrithioate (Tribufos, DEF) was added to the list of chemicals known to the state to cause cancer.
Feb 25, 2011, Program: Proposition 65
Release of the draft Interpretive Guideline No. 2011-001: Hand-to-mouth transfer of lead through exposure to consumer products.
Feb 25, 2011, Program: Proposition 65
Beginning of public review and comment period on OEHHA's interpretive guideline on how to estimate lead intake from the handling of consumer products in the context of Proposition 65.
Feb 25, 2011, Program: Proposition 65
Approved amendment to Title 27, California Code of Regulations, section 25705(b)(1), that adopt 8.2 micrograms per day as the No Significant Risk Level for 2,4,6-Trinitrotoluene (TNT) for purposes of Proposition 65.
Feb 25, 2011, Program: Proposition 65
OEHHA adds acrylamide (CAS No. 79-06-1) to the list of chemicals known to the state to cause reproductive toxicity
Feb 25, 2011, Program: Proposition 65
Availability for public review of the hazard identification document entitled: “Evidence on the Developmental and Reproductive Toxicity of Sulfur Dioxide."
Feb 25, 2011, Program: Proposition 65
Adoption of 0.54 micrograms per day as the No Significant Risk Level for glycidol for purposes of Proposition 65.
Feb 25, 2011, Program: Proposition 65
The hazard identification document entitled: “Evidence on the Developmental and Reproductive Toxicity of Sulfur Dioxide" is available for public comment. The DART IC meeting is scheduled for May 12 and 13, 2011.
Feb 25, 2011, Program: Proposition 65
Extension of comment period for the proposal to establish a specific regulatory level posing no significant risk for 4-methylimidazole by amending Title 27, California Code of Regulations, section 25705.
Feb 21, 2011, Program: Proposition 65